These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2371033)
1. Estrogen treatment of patients with established postmenopausal osteoporosis. Lindsay R; Tohme JF Obstet Gynecol; 1990 Aug; 76(2):290-5. PubMed ID: 2371033 [TBL] [Abstract][Full Text] [Related]
2. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis]. Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505 [TBL] [Abstract][Full Text] [Related]
3. The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis. Gonnelli S; Cepollaro C; Pondrelli C; Martini S; Monaco R; Gennari C J Bone Miner Res; 1997 Apr; 12(4):624-31. PubMed ID: 9101374 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience. Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620 [TBL] [Abstract][Full Text] [Related]
5. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover]. Celi M; Balducci S; Schiappoli A; Caliumi C; Petramala L; Cerci S; Cotesta D; D'Erasmo E; Letizia C Ann Ital Med Int; 2003; 18(2):89-98. PubMed ID: 12886826 [TBL] [Abstract][Full Text] [Related]
6. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study. Välimäki MJ; Laitinen K; Patronen A; Puolijoki H; Seppänen J; Pylkkänen L; Aranko SM; Sairanen S; Blåfield H; Rekiaro M; Väisänen K; Kormano M; Mäkinen L; Salmi J; Ala-Kaila K; Perttilä J; Vesterinen K; Koivunoro K; Osteoporos Int; 2002 Dec; 13(12):937-47. PubMed ID: 12459936 [TBL] [Abstract][Full Text] [Related]
7. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss]. Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868 [TBL] [Abstract][Full Text] [Related]
8. Long-term effect of calcium supplementation on bone loss in perimenopausal women. Elders PJ; Lips P; Netelenbos JC; van Ginkel FC; Khoe E; van der Vijgh WJ; van der Stelt PF J Bone Miner Res; 1994 Jul; 9(7):963-70. PubMed ID: 7942164 [TBL] [Abstract][Full Text] [Related]
9. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes]. Brodowska A Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843 [TBL] [Abstract][Full Text] [Related]
10. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis. Iwamoto J; Takeda T; Sato Y; Uzawa M J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627 [TBL] [Abstract][Full Text] [Related]
11. Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen. Suzuki Y; Whiting SJ; Davison KS; Chilibeck PD J Nutr Health Aging; 2003; 7(5):296-9. PubMed ID: 12917743 [TBL] [Abstract][Full Text] [Related]
12. The effects of plasma estradiol levels on increases in vertebral and femoral bone density following therapy with estradiol and estradiol with testosterone implants. Garnett T; Studd J; Watson N; Savvas M; Leather A Obstet Gynecol; 1992 Jun; 79(6):968-72. PubMed ID: 1579324 [TBL] [Abstract][Full Text] [Related]
13. Fluoride therapy for osteoporosis promotes a progressive increase in spinal bone density. Farley SM; Libanati CR; Mariano-Menez MR; Tudtud-Hans LA; Schulz EE; Baylink DJ J Bone Miner Res; 1990 Mar; 5 Suppl 1():S37-42. PubMed ID: 2339634 [TBL] [Abstract][Full Text] [Related]
14. [Effect of estrogen replacement therapy on the serum osteocalcin level in the postmenopausal and castrated women]. Honjo S; Mizunuma H; Soda M; Igarashi M Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1571-6. PubMed ID: 2555424 [TBL] [Abstract][Full Text] [Related]
15. Prevention of bone loss following oophorectomy in premenopausal women: a retrospective assessment of the effects of oophorectomy and a prospective controlled trial of the effects of mestranol therapy. Aitken JM; Hart DM; Lindsay R; Anderson JB; Smith DA; Wilson GM Isr J Med Sci; 1976 Jul; 12(7):607-14. PubMed ID: 972015 [TBL] [Abstract][Full Text] [Related]
17. [Influence of diet and physical activity on the course and therapy of osteoporosis]. Owecki M; Horst-Sikorska W; Baszko-Błaszyk D; Sowiński J Pol Merkur Lekarski; 2002 Dec; 13(78):473-6. PubMed ID: 12666444 [TBL] [Abstract][Full Text] [Related]
18. Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium. Melis GB; Paoletti AM; Bartolini R; Tosti Balducci M; Massi GB; Bruni V; Becorpi A; Ottanelli S; Fioretti P; Gambacciani M Bone Miner; 1992 Oct; 19 Suppl 1():S49-56. PubMed ID: 1422321 [TBL] [Abstract][Full Text] [Related]
19. [Osteoporosis and estrogens]. Metka M Wien Med Wochenschr; 1990 Oct; 140(18-19):485-6. PubMed ID: 2251842 [TBL] [Abstract][Full Text] [Related]
20. [Effect of estriol and bone mineral density of lumbar vertebrae in elderly and postmenopausal women]. Nishibe A; Morimoto S; Hirota K; Yasuda O; Ikegami H; Yamamoto T; Fukuo K; Onishi T; Ogihara T Nihon Ronen Igakkai Zasshi; 1996 May; 33(5):353-9. PubMed ID: 8741364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]